Connor, Clark & Lunn Investment Management (CC&L)
ONC

Connor, Clark & Lunn Investment Management (CC&L)’s BeOne Medicines Ltd ONC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-302,999
Closed -$73.3M – 1767
2025
Q2 		$73.3M Buy
302,999
+11,393
+4% +$2.79M 0.26% 76
2025
Q1 		$79.4M Buy
291,606
+7,212
+3% +$1.69M 0.35% 55
2024
Q4 		$52.5M Buy
284,394
+58,540
+26% +$12M 0.24% 71
2024
Q3 		$50.7M Buy
225,854
+138,978
+160% +$25M 0.25% 66
2024
Q2 		$12.4M Buy
86,876
+21,260
+32% +$3.28M 0.05% 249
2024
Q1 		$10.3M Buy
65,616
+32,252
+97% +$5.19M 0.04% 292
2023
Q4 		$6.02M Buy
33,364
+30,869
+1,237% +$5.58M 0.03% 375
2023
Q3 		$449K Sell
2,495
-14,331
-85% -$2.84M ﹤0.01% 1040
2023
Q2 		$3M Sell
16,826
-15,361
-48% -$3.54M 0.02% 501
2023
Q1 		$6.94M Sell
32,187
-18,758
-37% -$4.5M 0.04% 310
2022
Q4 		$11.2M Buy
50,945
+24,922
+96% +$4.57M 0.06% 211
2022
Q3 		$3.51M Buy
26,023
+18,417
+242% +$3.16M 0.02% 390
2022
Q2 		$1.23M Buy
7,606
+2,967
+64% +$463K 0.01% 571
2022
Q1 		$875K Buy
4,639
+3,404
+276% +$724K ﹤0.01% 690
2021
Q4 		$335K Buy
+1,235
New +$417K ﹤0.01% 869
2021
Q1 		– Sell
-7,833
Closed -$2.02M – 1113
2020
Q4 		$2.02M Buy
+7,833
New +$2.16M 0.01% 508

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ONC Position: Q3 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 302,999 shares — an estimated $73.3M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ONC in Q4 2020 and held it in 16 quarters. The position peaked at $79.4M in Q1 2025. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 302,999 BeOne Medicines Ltd shares in Q3 2025, an estimated $73.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 16 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s BeOne Medicines Ltd position peaked at $79.4M in Q1 2025.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2025, filed 13 Nov 2025.